Salmon Patrick, Trono Didier
Department of Neuroscience, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Curr Protoc Neurosci. 2006 Nov;Chapter 4:Unit 4.21. doi: 10.1002/0471142301.ns0421s37.
Lentiviral vectors have emerged over the last decade as powerful, reliable and safe tools for stable gene transfer in a wide variety of mammalian cells. Unlike other vectors derived from oncoretroviruses, they allow for stable gene delivery into most nondividing primary cells, including neurons. This is why LVs are becoming the most useful and promising tools in the field of neuroscience, not only for research, but also for future gene and cell therapy approaches. Lentivectors (LVs) derived from HIV-1 have gradually evolved to display many desirable features aimed at increasing both their safety and their versatility. These latest designs are reviewed in this unit. This unit also describes protocols for production and titration of LVs that can be implemented in a research laboratory setting, with an emphasis on standardization to improve transposability of results between laboratories.
在过去十年中,慢病毒载体已成为在多种哺乳动物细胞中进行稳定基因转移的强大、可靠且安全的工具。与其他源自嗜肝DNA病毒的载体不同,它们能够将基因稳定地导入大多数非分裂原代细胞,包括神经元。这就是慢病毒载体在神经科学领域正成为最有用且最具前景的工具的原因,不仅用于研究,也用于未来的基因和细胞治疗方法。源自HIV-1的慢病毒载体(LVs)已逐渐发展,展现出许多旨在提高其安全性和通用性的理想特性。本单元将对这些最新设计进行综述。本单元还描述了可在研究实验室环境中实施的慢病毒载体生产和滴定方案,重点在于标准化,以提高不同实验室之间结果的可转移性。